Smith Nicholas Conrad

US insider· US
Sign in for alerts
  • ACQUIREDT+7

    Alto Neuroscience Inc · NASDAQ

    +55,000 sh · $127.6K

    Filed 5 Oct 2026SEC Form 4view source
  • ACQUIREDT+30

    Alto Neuroscience Inc · NASDAQ

    +56,455 sh · $132.7K

    Filed 1 Oct 2026SEC Form 4view source
  • REDUCEDT+30

    Alto Neuroscience Inc · NASDAQ

    −886 sh · $23.8K

    Filed 1 Oct 2026SEC Form 4view source
  • REDUCEDT+30

    Alto Neuroscience Inc · NASDAQ

    −110,830 sh · $2.9M

    Filed 1 Oct 2026SEC Form 4view source
  • ACQUIREDT+30

    Alto Neuroscience Inc · NASDAQ

    +54,375 sh · $127.8K

    Filed 1 Oct 2026SEC Form 4view source
  • ACQUIREDT+30

    Alto Neuroscience Inc · NASDAQ

    +24,056 sh · $56.5K

    Filed 1 Oct 2026SEC Form 4view source
  • REDUCEDT+30

    Alto Neuroscience Inc · NASDAQ

    −23,170 sh · $597.3K

    Filed 1 Oct 2026SEC Form 4view source